Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Pharma Refuses to Ensure Equitable Access to HCV treatment at Global Meeting


Guru

Status: Offline
Posts: 1781
Date:
Pharma Refuses to Ensure Equitable Access to HCV treatment at Global Meeting
Permalink  
 


Big Pharma is playing their cards very close to their vest.

They are likely watching how it turns out for Gilead with India and China.

i would guess they will fall in line with the safest course rather than be the radical one company that could change the greed mode. .To bad all it would take is one of them to jump ship and be considerate to these poorer nations.

Time will tell

matt



__________________

"And in the end, the love you take is equal to the love you make"

61 year old Geno type A1, F4 Cirrhotic, started 24 weeks on Harvoni 12-17-14 ,EOT-5 week = UND, 8-31-15 =UND , SVR-24 Baby YES! 

Tig


Admin

Status: Offline
Posts: 9268
Date:
Permalink  
 

I believe Gilead is only doing that in India, maybe China because they stand to lose billions in USD$. They have made exceptions to their patent rights for those countries (thus far), because they were determined to ignore threats of litigation over patent right infringement. If Gilead gets their way, they'll try to restrict the use of those generic copies within the borders of the "offending" countries. I think they're only allowing it in these cases to mitigate their potential losses. Big Pharma has no limits to their greed...

Tig



__________________

Tig

67yo GT1A - 5 Mil - A2/F3 - (1996) Intron A - Non Responder, (2013) Peg/Riba/Vic SOT:05/23/13 EOT:12/04/13 SVR 9+ years!

Hep C FAQ   Lab Ref. Ranges  HCV Resistance

Signature Line Set Up/Abbreviations   Payment Assistance

 



Veteran Member

Status: Offline
Posts: 97
Date:
Permalink  
 

Hi,
This article seems to contradict what Gilead said in the enclosed link, any thoughts?
www.thehindubusinessline.com/companies/gilead-local-generic-players-in-talks-to-bring-hepatitis-c-drug-into-india/article5649841.ece


__________________

GT3a Age 61. Clinical trial sovaldi/riba 24 weeks. finished trial 17th April 2015 undetected. EOT+4 weeks undetected.24th July 2015 "SVR"

24 week SVR!!



Guru

Status: Offline
Posts: 5629
Date:
Permalink  
 

Bangkok, Thailand, February 28, 2014  - Thirty-eight activists from 22 countries joined forces at the first-ever Hepatitis C Virus (HCV) World Community Advisory Board (CAB) to demand equitable access to treatment for hepatitis C virus (HCV) from six multinational pharmaceutical companies.  Yet AbbVie, Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche refused to provide a plan for equitable access to treatment for HCV, a curable infection that kills over 350,000 people each year.

AIDS activists, including people living with HIV, people living with HCV, people who inject drugs (PWID), and their allies, are fighting for access to a new generation of HCV drugs - called direct-acting antivirals (DAAs).  These drugs offer the potential to eradicate HCV; they have cured up to 100 percent of people in clinical trials.

All of the companies refused to commit to price reductions that would allow affordable access for low- and middle-income countries (LMICs), home to more than 85 percent of the 185 million people living with HCV.  Even Roche and Merck, producers of older, soon-to-be-obsolete HCV drugs, refused to lower prices to affordable levels.

Full article...

http://hcvadvocate.blogspot.ca/2014/02/pharma-refuses-to-ensure-access-to.html



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.